Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells

Journal of Immunology

Volumn 179, Issue 6, 2007, Pages 3724-3733

  Kang, Seung G ^a   Lim, Hyung W ^a   Andrisani, Ourania M ^a   Broxmeyer, Hal E ^b   Kim, Chang H ^a  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; HISTONE; INTERLEUKIN 6; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; GROWTH INHIBITOR; HOMING RECEPTOR; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOL; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTESTINE LYMPH; INTESTINE MUCOSA; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; LYMPHOID TISSUE; MOUSE; MUCOSA CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY T LYMPHOCYTE; SMALL INTESTINE; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TARGET CELL; TH17 CELL; AKR MOUSE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; CLASSIFICATION; COCULTURE; CYTOLOGY; DRUG ANTAGONISM; GENETICS; HELPER CELL; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; FORKHEAD TRANSCRIPTION FACTORS; GROWTH INHIBITORS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-6; INTESTINAL MUCOSA; LYMPHOID TISSUE; MICE; MICE, INBRED AKR; MICE, INBRED BALB C; RECEPTORS, LYMPHOCYTE HOMING; RECEPTORS, RETINOIC ACID; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1; TRETINOIN; VITAMIN A;

EID: 35748934494     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.6.3724     Document Type: Article

References (60)

1. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24: 209-226.
2. + regulatory T cells in the hematolymphoid system. Exp. Hematol. 34: 1033-1040.
3. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162: 5317-5326.
4. Wan, Y. Y., and R. A. Flavell. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102: 5126-5131.
5. Fontenot, J. D., J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202: 901-906.
6. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6: 1219-1227.
7. + regulatory T cells by peripheral expansion. J. Immunol. 173: 7259-7268.
8. + T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J. Immunol. 178: 301-311.
9. Valmori, D., A. Merlo, N. E. Souleimanian, C. S. Hesdorffer, and M. Ayyoub. 2005. A peripheral circulating compartment of natural naive CD4 Tregs. J. Clin. Invest. 115: 1953-1962.
10. + regulatory T cells. J. Immunol. 177: 840-851.
11. + regulatory T cells bear functional skin-homing receptors. J. Immunol. 177: 4488-4494.
12. Chatila, T. A., F. Blaeser, N. Ho, H. M. Lederman, C. Voulgaropoulos, C. Helms, and A. M. Bowcock. 2000. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106: R75-81.
13. Bennett, C. L., J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance, and H. D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27: 20-21.
14. Wildin, R. S., F. Ramsdell, J. Peake, F. Faravelli, J. L. Casanova, N. Buist, E. Levy-Lahad, M. Mazzella, O. Goulet, L. Perroni, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27: 18-20.
15. Beyer, M., and J. L. Schultze. 2006. Regulatory T cells in cancer. Blood 108: 804-811.
16. + T cells accumulate in lung adenocarcinoma. J. Immunol. 177: 6983-6990.
17. high T cells are enriched in the tumor and peripheral blood of prostate cancer patients. J. Immunol. 177: 7398-7405.
18. + regulatory T cells are numerically deficient in acute and chronic GvHD. Blood 107: 1717-1723.
19. Cantorna, M. T., F. E. Nashold, and C. E. Hayes. 1994. In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J. Immunol. 152: 1515-1522.
20. Racke, M. K., D. Burnett, S. H. Pak, P. S. Albert, B. Cannella, C. S. Raine, D. E. McFarlin, and D. E. Scott. 1995. Retinoid treatment of experimental allergic encephalomyelitis: IL-4 production correlates with improved disease course. J. Immunol. 154: 450-458.
21. Hoag, K. A., F. E. Nashold, J. Goverman, and C. E. Hayes. 2002. Retinoic acid enhances the T helper 2 cell development that is essential for robust antibody responses through its action on antigen-presenting cells. J. Nutr. 132: 3736-3739.
22. Stephensen, C. B., R. Rasooly, X. Jiang, M. A. Ceddia, C. T. Weaver, R. A. Chandraratna, and R. P. Bucy. 2002. Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway. J. Immunol. 168: 4495-4503.
23. Iwata, M., Y. Eshima, and H. Kagechika. 2003. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int. Immunol. 15: 1017-1025.
24. Tokuyama, Y., and H. Tokuyama. 1996. Retinoids as Ig isotype-switch modulators. Cell. Immunol. 170: 230-234.
25. Pasatiempo, A. M., M. Kinoshita, C. E. Taylor, and A. C. Ross. 1990. Antibody production in vitamin A-depleted rats is impaired after immunization with bacterial polysaccharide or protein antigens. FASEB J. 4: 2518-2527.
26. Smith, S. M., and C. E. Hayes. 1987. Contrasting impairments in IgM and IgG responses of vitamin A-deficient mice. Proc. Natl. Acad. Sci. USA 84: 5878-5882.
27. Yang, Y., M. S. Vacchio, and J. D. Ashwell. 1993. 9-cis-retinoic acid inhibits activation-driven T-cell apoptosis: implications for retinoid X receptor involvement in thymocyte development. Proc. Natl. Acad. Sci. USA 90: 6170-6174.
28. Iwata, M., M. Mukai, Y. Nakai, and R. Iseki. 1992. Retinoic acids inhibit activation-induced apoptosis in T cell hybridomas and thymocytes. J. Immunol. 149: 3302-3308.
29. Wiedermann, U., A. Tarkowski, T. Bremell, L. A. Hanson, H. Kahu, and U. I. Dahlgren. 1996. Vitamin A deficiency predisposes to Staphylococcus aureus infection. Infect. Immun. 64: 209-214.
30. Iwata, M., A. Hirakiyama, Y. Eshima, H. Kagechika, C. Kato, and S. Y. Song. 2004. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21: 527-538.
31. Sirisinha, S., M. D. Darip, P. Moongkarndi, M. Ongsakul, and A. J. Lamb. 1980. Impaired local immune response in vitamin A-deficient rats. Clin. Exp. Immunol. 40: 127-135.
32. Johansson-Lindbom, B., S. Ingvarsson, and C. A. Borrebaeck. 2003. Germinal centers regulate human Th2 development. J. Immunol. 171: 1657-1666.
33. Mora, J. R., M. R. Bono, N. Manjunath, W. Weninger, L. L. Cavanagh, M. Rosemblatt, and U. H. Von Andrian. 2003. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424: 88-93.
34. + T cells display CCR9-dependent and -independent homing to the small intestine. Blood 107: 3447-3454.
35. Mora, J. R., M. Iwata, B. Eksteen, S. Y. Song, T. Junt, B. Senman, K. L. Otipoby, A. Yokota, H. Takeuchi, P. Ricciardi-Castagnoli, et al. 2006. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 314: 1157-1160.
36. Shams, N. B., C. V. Reddy, K. Watanabe, S. A. Elgebaly, L. A. Hanninen, and K. R. Kenyon. 1994. Increased interleukin-1 activity in the injured vitamin A-deficient cornea. Cornea 13: 156-166.
37. Vladutiu, A., and N. Cringulescu. 1968. Suppression of experimental allergic encephalomyelitis by vitamin A. Experientia 24: 718-719.
38. Wang, T., S. Niwa, K. Bouda, S. Matsuura, T. Homma, K. Shudo, and H. Nagai. 2000. The effect of Am-80, one of retinoids derivatives on experimental allergic encephalomyelitis in rats. Life Sci. 67: 1869-1879.
39. Szondy, Z., U. Reichert, and L. Fesus. 1998. Retinoic acids regulate apoptosis of T lymphocytes through an interplay between RAR and RXR receptors. Cell Death Differ. 5: 4-10.
40. Aukrust, P., F. Muller, T. Ueland, A. M. Svardal, R. K. Berge, and S. S. Froland. 2000. Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses. Eur. J. Clin. Invest. 30: 252-259.
41. + germinal center-T cells are the major helpers for GC-B cells and induce class switch recombination. BMC Immunol. 6: 3.
42. Kim, C. H., E. J. Kunkel, J. Boisvert, B. Johnston, J. J. Campbell, M. C. Genovese, H. B. Greenberg, and E. C. Butcher. 2001. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J. Clin. Invest. 107: 595-601.
43. Grossman, W. J., J. W. Verbsky, W. Barchet, M. Colonna, J. P. Atkinson, and T. J. Ley. 2004. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21: 589-601.
44. + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108: 1571-1579.
45. Mantel, P. Y., N. Ouaked, B. Ruckert, C. Karagiannidis, R. Welz, K. Blaser, and C. B. Schmidt-Weber. 2006. Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 176: 3593-3602.
46. Jenuwein, T., and C. D. Allis. 2001. Translating the histone code. Science 293: 1074-1080.
47. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
48. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-β induces development of the T(H)17 lineage. Nature 441: 231-234.
49. Mark, M., N. B. Ghyselinck, and P. Chambon. 2006. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu. Rev. Pharmacol. Toxicol. 46: 451-480.
50. Chambon, P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10: 940-954.
51. Bourguet, W., P. Germain, and H. Gronemeyer. 2000. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol. Sci. 21: 381-388.
52. Sedjo, R. L., J. Ranger-Moore, J. Foote, N. E. Craft, D. S. Alberts, M. J. Xu, and A. R. Giuliano. 2004. Circulating endogenous retinoic acid concentrations among participants enrolled in a randomized placebo-controlled clinical trial of retinyl palmitate. Cancer Epidemiol. Biomarkers Prev. 13: 1687-1692.
53. + T cells and dendritic cells in vivo. J. Exp. Med. 203: 505-511.
54. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194: 629-644.
55. + regulatory T cells by oral antigen administration. J. Immunol. 167: 4245-4253.
56. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6: 338-344.
57. Choi, B. M., H. O. Pae, Y. R. Jeong, Y. M. Kim, and H. T. Chung. 2005. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem. Biophys. Res. Commun. 327: 1066-1071.
58. + regulatory T cells. J. Exp. Med. 199: 303-313.
59. Lim, H. W., P. Hillsamer, and C. H. Kim. 2004. Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J. Clin. Invest. 114: 1640-1649.
60. + T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 104: 3804-3812.